SINOPHARM COVID-19 VACCINE
The world is in the midst of a COVID-19 pandemic. As WHO and partners work together on the response – tracking the pandemic, advising on critical interventions, distributing vital medical supplies to those in need – they are racing to develop and deploy safe and effective vaccines.
Vaccines save millions of lives each year. Vaccines work by training and preparing the body’s natural defences – the immune system – to recognize and fight off the viruses and bacteria they target. If the body is exposed to those disease-causing germs later, the body is immediately ready to destroy them, preventing illness.
For the prevention of 2019 coronavirus disease (COVID-19) for individuals 16 years of age and older
SARS-CoV-2 Vaccine (Vero cell), Inactivated
The hepatitis A vaccine Healive® is the first HepA vaccine in China to pass WHO-PQ, and is being exported to more than 10 “Belt and Road” countries and international organizations such as UNICEF and PAHO.
Worldwide Market & Footprint
Sinopharm’s vaccine has been sold in 54 countries around the world, over 2 billion people were vaccinated.
Total GMPs: 54 Certificates
Qualified by World Health Organization